Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On January 6, 2020, Karen Flynn, a member of the Board of Directors (the
"Board") of Recro Pharma, Inc. (the "Company"), notified the Company of her
intention to resign from the Board effective January 8, 2020. Ms. Flynn resigned
to focus on her new role with Catalent, Inc., a provider of advanced delivery
technologies and development solutions for drugs, biologics, and consumer health
products and to avoid any potential future conflict of interest. Ms. Flynn's
decision to resign did not result from any disagreement with the Company. The
Company has appreciated Ms. Flynn's contributions to the Board and thanks her
for her service.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses